CODX
Price:
$1.34
Market Cap:
$42.76M
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify gen...[Read more]
Industry
Medical - Devices
IPO Date
2017-07-12
Stock Exchange
NASDAQ
Ticker
CODX
According to Co-Diagnostics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.06. This represents a change of 2.25% compared to the average of -1.04 of the last 4 quarters.
The mean historical PE Ratio of Co-Diagnostics, Inc. over the last ten years is -11.17. The current -1.06 PE Ratio has changed 848.94% with respect to the historical average. Over the past ten years (40 quarters), CODX's PE Ratio was at its highest in in the June 2020 quarter at 10.56. The PE Ratio was at its lowest in in the March 2020 quarter at -40.81.
Average
-11.17
Median
-3.56
Minimum
-43.54
Maximum
7.03
Discovering the peaks and valleys of Co-Diagnostics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 20.24%
Maximum Annual PE Ratio = 7.03
Minimum Annual Increase = -336.73%
Minimum Annual PE Ratio = -43.54
Year | PE Ratio | Change |
---|---|---|
2023 | -1.10 | -80.17% |
2022 | -5.57 | -179.21% |
2021 | 7.03 | 20.24% |
2020 | 5.85 | -336.73% |
2019 | -2.47 | -16.69% |
2018 | -2.97 | -28.66% |
2017 | -4.16 | -87.52% |
2016 | -33.32 | 5.94% |
2015 | -31.45 | -27.77% |
The current PE Ratio of Co-Diagnostics, Inc. (CODX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
0.12
5-year avg
0.75
10-year avg
-11.17
Co-Diagnostics, Inc.’s PE Ratio is less than Heart Test Laboratories, Inc. (-0.29), less than NanoVibronix, Inc. (-0.59), less than Rapid Micro Biosystems, Inc. (-0.72), less than ThermoGenesis Holdings, Inc. (-0.07), less than Biomerica, Inc. (-0.98), less than Nemaura Medical Inc. (-0.13), less than Bluejay Diagnostics, Inc. (-0.01), greater than Movano Inc. (-1.15), less than INVO Bioscience, Inc. (-0.38), greater than enVVeno Medical Corporation (-4.05), less than Tivic Health Systems, Inc. (-0.19), less than Bone Biologics Corporation (-0.27), less than Vivos Therapeutics, Inc. (-0.70), greater than Senseonics Holdings, Inc. (-2.47), greater than Inogen, Inc. (-2.89), greater than ClearPoint Neuro, Inc. (-18.16), greater than NeuroPace, Inc. (-6.95), greater than Surmodics, Inc. (-393.30), greater than CVRx, Inc. (-3.35), less than NeuroMetrix, Inc. (-0.95), less than ReShape Lifesciences Inc. (-0.41), greater than Inspira Technologies Oxy B.H.N. Ltd. (-1.56), less than OpGen, Inc. (-0.12),
Company | PE Ratio | Market cap |
---|---|---|
-0.29 | $2.52M | |
-0.59 | $1.65M | |
-0.72 | $35.83M | |
-0.07 | $3.96M | |
-0.98 | $5.84M | |
-0.13 | $1.13M | |
-0.01 | $935.33K | |
-1.15 | $30.77M | |
-0.38 | $2.95M | |
-4.05 | $69.18M | |
-0.19 | $2.03M | |
-0.27 | $2.14M | |
-0.70 | $8.91M | |
-2.47 | $172.72M | |
-2.89 | $268.02M | |
-18.16 | $328.11M | |
-6.95 | $210.22M | |
-393.30 | $553.99M | |
-3.35 | $183.44M | |
-0.95 | $7.64M | |
-0.41 | $4.32M | |
-1.56 | $19.92M | |
-0.12 | $16.29M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Co-Diagnostics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Co-Diagnostics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Co-Diagnostics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Co-Diagnostics, Inc. (CODX)?
What is the highest PE Ratio for Co-Diagnostics, Inc. (CODX)?
What is the 3-year average PE Ratio for Co-Diagnostics, Inc. (CODX)?
What is the 5-year average PE Ratio for Co-Diagnostics, Inc. (CODX)?
How does the current PE Ratio for Co-Diagnostics, Inc. (CODX) compare to its historical average?